Bicara Therapeutics Inc. · NASDAQ:BCAX
BlackRock, Inc. reported a 5.40% stake in Bicara Therapeutics Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Jul 27, 2026
BlackRock, Inc. reported a 5.40% stake in Bicara Therapeutics Inc., 3,536,271 shares, as a passive investor on Jun 30, 2026. Filed Jul 27, 2026 (Schedule 13G).
- Stake
- 5.40%
- Shares
- 3,536,271
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 5.40% | 3,536,271 |
Source
Related
- Bicara Therapeutics Inc.
- BlackRock, Inc.
- Bicara Therapeutics Inc. shareholders
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · Oct 7, 2026
- Form 4 · Cohlhepp Ryan · Sep 10, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Aug 13, 2026
- Form 4 · Hyep Ivan · Aug 12, 2026
- Form 4 · Mazumdar Claire · Aug 12, 2026